Pancreatogastrostomy vs. pancreatojejunostomy for reconstruction of the pancreatic remnant after pancreatoduodenotomy: a prospective, randomised, controlled, metacentre study

Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)0 个研究点目标入组 130 人开始时间: 2013年2月7日最近更新: 2016年11月28日

适应症

试验速览

暂无简介。

•1. Consecutive patients who will undergo pancreatodudodenectomy (DPC) at Hospital Clinico de Valencia and Hospital ?Dr Josep Trueta? in Girona Spain. Coordinated by ?Dr Josep Trueta? Hospital of Girona
•2. Patients aged 18 to 80 years, either sex
•3. Pancreatectomy is indicated because of a benign or malignant tumour of the pancreas, chronic pancreatitis or malignant neoplasm of other organs infiltrating the pancreas, provided the parenchyma of the pancreas is suitable for anastomosis

•1. Patients who at the time of surgery are found not resectable
•2. Associated resection of other organs, excluding the superior mesenteric vein
•3. American Society of Anaesthesiologists (ASA) anesthetic risk 4 as the American Association of Anesthesiologists
•4. Pancreatoduodenectomy (PD) for calcifying chronic pancreatitis
•5. PD palliative leaving macroscopic tumor
•6. Preoperative obstructive jaundice with bilirubin> 300µmol or 15 mg/

发起方

Carlos III Institute of Health (Instituto de Salud Carlos III) (Spain)